ArticleCureus2025
Robotic Resection of Colonic Medullary Carcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medullary Carcinoma of the Colon: A Case Report.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal medullary carcinoma (MC) is a rare and distinct subtype of colorectal cancer associated with mismatch repair (MMR) deficiency with the loss of MLH1 and PMS2 genes. Due to its rare incidence and atypical histopathological features, MC is often misclassified as a poorly differentiated adenocarcinoma. We present the case of an 87-year-old elderly male with iron deficiency anemia and a right-sided abdominal mass. Initial colonoscopy biopsy reported a poorly differentiated adenocarcinoma, but subsequent surgical resection confirmed MC. The patient elected to undergo a right hemicolectomy via a robotic-assisted approach. Although the potential oncologic benefit of robotic surgery remains uncertain, it was chosen in this case due to the patient's preference for a minimally invasive procedure, his advanced age, and the tumor's relatively large size. No adjuvant therapy was recommended after a multidisciplinary review given the tumor's MMR deficiency and absence of regional lymph node metastasis. This report highlights the diagnostic challenges of MC and the potential benefits of a robotic approach for MC resections in an elderly patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.